Search filters

List of works by Marina Martello

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study

scientific article published on 17 September 2014

Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.

scientific article published on 10 May 2013

Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma.

scientific article

HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.

scientific article published on 26 September 2014

Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.

scientific article published on April 2014

Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma

scientific article published on 26 February 2020

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives

scientific article published on 20 August 2019

Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma

scientific article

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis

scientific article published on 14 April 2016

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

scientific article published on 15 June 2015

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

scientific article published on 9 November 2015

Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.

scientific article published on 11 December 2014

Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model

scientific article published on 19 July 2018